Unternehmen wird geladen
Just reported
Q3 FY2027 results
From Usana Health Sciences's results release of 3. November 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
205,9M $
-3,6 % y/y
-7,8 % q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Usana Health Sciences is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Packaged Foods
Graded A or B and worth $2B or more: A first, then the largest.
SJMJ M Smucker Co14,2B $A
MKCMccormick & Company, Incorporated12,7B $A+
FRPTFreshpet, Inc.3,3B $A
DARDarling Ingredients Inc.8,7B $B+
POSTPost Holdings, Inc.3,6B $B
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SA30. Juli 2026BAGraded B, now A
MDLZMondelez International, Inc.29. Okt. 2026CAGraded C, now A
HSYHershey Co.29. Okt. 2026BAGraded B, now A
SYYSysco Corporation4. Nov. 2026BAGraded B, now A
ELFe.l.f. Beauty, Inc.4. Nov. 2026BAGraded B, now A
Gebaut aus den eigenen Einreichungen von Usana Health Sciences, Inc. bei der US-Börsenaufsicht Securities and Exchange Commission (SEC). Die Zahlen sind wie berichtet, die Historie je Aktie auf die heutige Aktienbasis umgerechnet. Dies beschreibt ein Unternehmen — es ist keine Anlageberatung und keine Kauf- oder Verkaufsempfehlung.
